SimplicardiacS.A.
Other research and experimental development on natural sciences and engineering
Overview
Simplicardiac is dedicated to automated arterial access site management, providing solutions that enhance outcomes and reduce costs in endovascular procedures. The company offers the Simpliactive bots and platform, which automate access site management by mimicking manual compression and controlling bleeding throughout the healing process. Their technology is designed to address complications related to access sites in interventional cardiovascular procedures.
Financials
The financial statement for 2024 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2023.
Results vs industry
Industry
Bank accounts
Was a VAT taxpayer from 2013-03-13 to 2025-09-09. Removed from VAT register
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 2, 2020 | Aid for SMEs for innovation support | $92,585$92,585 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2019-08-01 | Ochrona prawna własności przemysłowej dla wynalazku "Urządzenie medyczne do ucisku naczynia krwionośnego" | $94,032$94,032 | Program Operacyjny Inteligentny Rozwój |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
Each member of the management board is entitled to perform legal acts and make declarations on behalf of the company independently.
Supervisory board
Beneficial owners
| Person | Rights | |
|---|---|---|
Michał Marcin Kojecki (58)  | Pan michał kojecki jest beneficjentem fundacji simko i jest jej fundatorem , a fundacja ta posiada 100% udziałów w acrx investments. |
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Cardioboticssp. z o.o. | 1,593.73 USD | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Dicellasp. z o.o. | $206,073.49 | dicella.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| SatroecgS.A. | $117,301.57 | satroecg.pl | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| ATER Netsp. z o.o. | $58,127.56 | aternet.pl | ||
| Advanced Diagnostic Equipmentsp. z o.o. | $43,171.56 | adediabetics.pl | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Edoktor24 Servicessp. z o.o. | $34,089.64 | edoktor24.pl | ||
| EFMS.A. | $8,156.49 | engineers4medicine.com | ||
| Poltisssp. z o.o. | $3,843.72 | poltiss.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-12-12 | Share capital change (293,291.00 PLN → 891,231.00 PLN) | |
| 2024-06-24 | Share capital change (282,691.00 PLN → 293,291.00 PLN) | |
| 2024-04-26 | Share capital change (200,800.00 PLN → 282,691.00 PLN) | |
| 2021-12-13 | Entered in the register |
FAQ
Last updated: 2026-04-01